The purpose of this study is to evaluate the safety and efficacy of KWA-0711 in Chronic Constipation (CC) patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
37
Unnamed facility
Tokyo, Japan
Incidence of Adverse Events
Time frame: 2 weeks
Change in fasting and postprandial blood glucose levels
Time frame: 2 weeks
Change in fasting and postprandial insulin levels
Time frame: 2 weeks
ECGs, vital signs, and clinical labs
Time frame: 2 weeks
Improvement of signs and symptoms associated with constipation
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.